Enobia Pharma
VerifiedAlexion Pharmaceuticals, Inc (NASDAQ: ALXN) | World Leader in Treatments for Patients with Devastating and Rare Diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$160—240m (Dealroom.co estimates Aug 2011.)
Montreal Quebec (HQ)
No columns specified